Jason M Link

5PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 10, 2026
Epigenetic progression of pancreatic cancer to aggressive subtypes involves alternate routes of lineage reprogramming in subtype-intermediate progenitor cells.

|Jan 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial.

Zev A Wainberg, Jason M Link, Alykhan Premji

|Sep 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer.

Chloe L Bowman, Colin J Daniel, Eric J Carlson

|Jan 09, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer.

Jason M Link, Jennifer R Eng, Carl Pelz

|May 17, 2023
MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN Signaling.

Razmik Ghukasyan, Keke Liang, Kevin Chau

Pageof 1

Frequent Collaborators

3 joint publications

Ellen M Langer

3 joint publications

Andrew C Adey

3 joint publications

Jennifer R Eng

3 joint publications

Rosalie C Sears